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High blood levels of ammonia are observed in several pathological conditions 
such as cirrhosis of the liver and inborn errors of the urea cycle. Elevated blood 
ammonia levels are toxic to the brain and central nervous system and lead to 
convulsions, coma, and death. Recent interest has centered on reducing elevated 
blood ammonia by increasing nitrogen excretion in the form of derived conjugates 
(1). A number of compounds that can protect animals against ammonia toxicity 
have been tested. These compounds include sodium benzoate, ethanol, pheny- 
lacetate, and carbamyl glutamate (2). 
O’Connor et al. recently reported that an intraperitoneal injection of L-carnitine 
protected mice against ammonia toxicity (3,4). They proposed that L-carnitine 
induced ureagenesis, resulting in decreased ammonia levels in blood and brain. 
The initial objective of our investigation was to confirm this observation in 2- 
month-old ferrets which develop severe ammonia toxicity within 2 hr after eating 
an arginine-free diet (5). Preliminary results showed that L-carnitine did not 
protect ferrets against the diet-induced ammonia toxicity. Therefore, we attempted 
to confirm the observation of the effects of L-carnitine on the mortality and 
ammonia levels in plasma, brain, and liver in mice. Our study shows that L- 
camitine failed to protect mice and ferrets from ammonia toxicity. 
MATERIALS AND METHODS 
A powder form of L-carnitine hydrochloride was purchased from Sigma Chemical 
Co. (St. Louis, MO) and an injectable form of L-carnitine was purchased from 
Sigma-tau Co. (Rome, Italy). Other chemicals used were of analytical grade. 
Animals. Male Swiss Albino mice, weighing 25-30 g, were purchased from 
Charles River Laboratories (Wilmington, ME) and were maintained on Purina 
rodent chow. Two month-old, male, sable-coated ferrets were purchased from 
Marshall Farm (North Rose, NY) and were maintained on Purina cat chow. An 
arginine-free diet was prepared as described previously (5, 6). 
Experimental design. Twelve ferrets were divided into two groups of six animals 
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TABLE 1 
Effect of L-Camitine on Mortality in Mice Challenged with Ammonium Acetate” 
Treatment 




Saline 8 0 0 
L-carnitine 6 0 0 
Saline + ammonium acetate 14 IO 71 
Carnitine + ammonium acetate 19 I5 79 
a Mice were injected ip with either saline or with L-carnitine (16 mmole/kg). Thirty minutes later, 
ammonium acetate was injected (ip. 14 mmole/kg) and mice were observed for mortality. 
each. All ferrets were fasted for 16 hr and then fed an arginine-free diet at 9:00 
AM. At lo:30 AM ferrets in group 1 were injected (ip) with saline and ferrets in 
group 2 were injected intraperitoneally (ip) with 8 mmoles/kg of L-carnitine. At 
12:30 PM blood was collected in chilled heparinized tubes and centrifuged at 
6000g for 15 min and plasma was separated. Ammonia in plasma was determined 
as described below. 
Preliminary experiments were conducted in mice to determine the lethal dose 
of ammonium acetate. Mice were injected (ip) with an increasing dose of ammonium 
acetate ranging from l-18 mmole/kg and the effect on mortality was studied. 
In other experiments (Tables 1 and 2) mice were divided into four groups as 
follows: 1, saline; 2, L-carnitine; 3, saline plus ammonium acetate; and 4, L- 
carnitine plus ammonium acetate. Mice from groups 1 and 3 were injected (ip) 
with 0.5 ml of saline and mice in groups 2 and 4 were injected (ip) with 16 
TABLE 2 
Effects of L-Camitine and Ammonium Acetate on Ammonia and Urea Levels in Serum, Liver, 
and Brain of Mice” 
Parameter Saline L-Carnitine 
L-Carnitine plus 
Saline plus ammonium 
ammonium acetate acetate 
Ammoniab 
Serum (~mole/liter) 234 f 24 474 2 45 3561 ir 392 4784 * 564 
Liver (pmole/g) 2.4 + 0.5 1.3 +- 0.1’ 7.7 -t 0.7 9.9 t 0.8'.d 
Brain @mole/g) 3.3 2 0.2 2.1 +- 0.1’ 3.7 2 0.5 4.5 k 0.4‘ 
Urea 
Serum (mmole/liter) 11.3 2 0.6 12.6 % 0.7 15.0 2 0.9 15.8 ? 0.6 
Liver (pmole/g) 4.9 f 0.5 8.2 k 0.3' 11.2 k 0.8' 12.0 A 0.3" 
Brain &mole/g) 4.9 t 0.3 7.8 f 0.4' 7.0 k 0.3' 8.5 k 0.4 
0 Injections were administered as described in Table 1. Five minutes after the ammonium acetate 
injection, blood, liver, and brains were removed. 
’ Results are means + SEM. n > 9. Statistically significant differences (P < 0.05) are indicated 
by ’ when compared with the saline group and ’ when compared with the saline plus ammonium 
acetate group. 
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mmole/kg of L-carnitine. Thirty minutes later ammonium acetate (14 mmole/kg, 
as 0.8 M solution) was injected (ip) into mice from groups 3 and 4. In the first 
part of the experiment (Table I), the mortality was studied. In the second part 
(Table 2), a similar protocol was followed except that mice were sacrified 5 min 
after ammonium acetate injection. Blood was collected from the heart. The brains 
and livers were quickly removed and immediately frozen in liquid nitrogen. 
Ammonia and urea were measured in serum, plasma, and brain within 3 hr after 
sample collection. 
Ammonia and urea assays. To separate serum, blood was allowed to clot at 
0°C for 15 min and centrifuged in a refrigerated centrifuge at 7000g for 15 min. 
Brain and liver samples were homogenized in chilled perchloric acid (1 M). 
Homogenates were centrifuged at 10,OOOg for 15 min, 0-2”C, and the supernatants 
were neutralized to pH 7.00 with 1 N sodium hydroxide. Ammonia (7) and urea 
(8) were determined in the serum and supernatants. 
Statistical analysis. Values are expressed as means + SEM. Differences were 
analyzed by a Student t test and considered statistically significant when P < 
0.05. 
RESULTS AND DISCUSSION 
L-Carnitine has been reported to protect mice from ammonia toxicity (3,4). 
To test whether L-carnitine also protects other species from ammonia toxicity, 
we conducted preliminary experiments in ferrets. Within 2 hr after eating an 
arginine free diet, ferrets from both groups developed symptoms of hyperam- 
monemia such as seizures, convulsions, and coma. The severity and duration 
of sickness was similar in the two groups. Plasma ammonia levels were not 
significantly different in the two groups (data not shown). 
Since L-carnitine failed to protect ferrets from ammonia toxicity, we examined 
the effect of carnitine in mice (Tables 1 and 2) using a previously published 
protocol (3,4). To avoid discrepancies in results due to differences in animals 
or chemicals, we purchased the same strain of mice and obtained t,-carnitine 
from the same source. The only difference was that O’Connor et al. collected 
the blood from the tail vein, whereas we collected it from the heart, as we were 
unable to collect sufficient blood from the tail veins of animals administered 
ammonium acetate. 
In preliminary experiments some symptoms of hyperammonemia such as lethargy 
and shivering were observed in mice injected with 8 mmole/kg of ammonium 
acetate. Although mice injected with 12 mmole/kg ammonium acetate showed 
symptoms of hyperammonemia, all mice recovered within 20 min. This is in 
contrast to the findings of O’Connor et al. (4), who reported the LDloo to be 12 
mmole/kg. At higher concentrations of ammonium acetate (14-18 mmole/kg), 
mice showed more severe symptoms of ammonia toxicity such as convulsions, 
seizures, and death. Severity of symptoms increased with increased dose of 
ammonium acetate. At a 14 mmole/kg dose, more than 70% of the mice died 
within 8-12 min of the ammonium acetate injection. 
Mice injected only with L-camitine exhibited no visible toxic effects during a 
24-hr observation period (Table 1). However, compared to saline-treated controls, 
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these animals had increased ammonia in serum and increased urea in liver and 
brain (Table 2). The ammonia levels in liver and brain were much lower than 
those of saline-treated controls. 
Intraperitoneal injection of L-camitine (16 mmole/kg) did not abolish or alleviate 
the symptoms of hyperammonemia induced by ammonium acetate injection, 
These mice succumbed as rapidly as those injected with saline plus ammonium 
acetate. 
We found no statistically significant difference in mortality between mice treated 
with either saline or L-carnitine prior to ammonium acetate injection (Table 1). 
O’Connor et al. (4) reported that pretreatment with 16 mmole/kg of L-carnitine 
protected 100% of mice from ammonia toxicity, whereas we found that more 
than 75% of mice pretreated with L-carnitine died within 10 min of ammonium 
acetate challenge. Similar mortality rates were obtained when L-carnitine was 
injected 15 min prior to the ammonium acetate challenge (data not shown). 
Identical results were obtained using L-carnitine from another commercial source 
(Sigma). 
Intraperitoneal injection of ammonium acetate into mice caused a rapid increase 
in serum and liver ammonia but did not alter the brain ammonia (Table 2). This 
may be expected, as an ip injection would cause changes in liver first. Our results 
are again in contrast to those of O’Connor et al. (4), who reported that brain 
ammonia elevated rapidly in the animals that received ammonium acetate injection. 
We could not compare our brain ammonia values with those of O’Connor et al. 
(4) because they have expressed brain ammonia as millimolars without indication 
of tissue concentration, 
Mice treated with L-carnitine plus ammonium acetate had higher levels of 
ammonia in the liver than mice injected with saline plus ammonium acetate 
(Table 2). This is probably due to an increased load of nitrogen derived from 
the carnitine. Although serum and brain ammonia levels were higher in carnitine- 
plus ammonium acetate-treated animals than those in the saline plus ammonium 
acetate group, the differences were not statistically significant. 
O’Connor et al. (4) reported that L-carnitine induced the urea synthesis and 
thereby lowered blood and brain ammonia. An injection of ammonium acetate 
or L-camitine caused a rapid increase in urea in liver and brain (Table 2) indicating 
that part of the ammonia may have been converted into urea via the urea cycle. 
We found that L-carnitine did not cause any additional increase in the urea levels 
in serum, brain, or liver above that obtained with ammonium acetate alone (Table 
2). 
In conclusion, our study shows that L-camitine treatment did not protect mice 
or ferrets against ammonia toxicity. On the contrary, injection of L-carnitine 
produced an increase in the plasma ammonia levels. These results suggest that 
the effects of L-carnitine on ammonia toxicity in animals require more detailed 
study if the results are to be used as a guide to human experimentation. 
SUMMARY 
Recent reports indicate that intraperitoneal administration of L-carnitine protects 
mice from ammonia toxicity. We found that mice injected with L-carnitine and 
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subsequently challenged with ammonium acetate succumb as readily as mice 
injected with saline and the ammonium acetate. Mice pretreated with L-camitine 
exhibited higher levels of liver ammonia than the saline-pretreated control mice. 
The ammonia and urea levels in serum and brains were similar in two groups. 
Our findings are in contrast to those reported previously and therefore warrants 
further investigation before L-carnitine can be considered as a drug to alleviate 
hyperammonemia in humans. 
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